What is he best known for?
The fields of study he is best known for:
Andrew Thorburn mostly deals with Autophagy, Cell biology, Programmed cell death, Cancer and Cancer research.
His Autophagy study deals with Metastasis intersecting with Cell cycle and Downregulation and upregulation.
His Cell biology research incorporates elements of Carcinogenesis, Tumor progression, Tumor Escape and Mitophagy.
Programmed cell death is a subfield of Apoptosis that Andrew Thorburn investigates.
The concepts of his Cancer study are interwoven with issues in Cell, PI3K/AKT/mTOR pathway, Immunology and Pharmacology.
His Autophagosome membrane study combines topics from a wide range of disciplines, such as MAP1LC3B, Chaperone-mediated autophagy, BECN1 and Autolysosome.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. (1421 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Autophagy, Cell biology, Cancer research, Apoptosis and Programmed cell death.
His study looks at the intersection of Autophagy and topics like Cancer with Pharmacology and Cell culture.
His Cell biology research is multidisciplinary, relying on both Receptor, FADD, Death domain and Fas ligand.
His work deals with themes such as Cell cycle, Gene knockdown, Immunology and In vivo, which intersect with Cancer research.
In the field of Apoptosis, his study on Caspase overlaps with subjects such as Population.
His Programmed cell death study combines topics in areas such as Necrosis and Neuroscience.
He most often published in these fields:
- Autophagy (51.30%)
- Cell biology (46.11%)
- Cancer research (35.75%)
What were the highlights of his more recent work (between 2017-2021)?
- Autophagy (51.30%)
- Cancer research (35.75%)
- Cell biology (46.11%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Autophagy, Cancer research, Cell biology, Programmed cell death and Cancer.
His Autophagy study is concerned with Apoptosis in general.
His Cancer research research includes themes of Cytotoxic T cell, PTPN13, Protein tyrosine phosphatase and In vivo.
His study in the field of Organelle also crosses realms of Autoregulation.
His Programmed cell death study incorporates themes from Neuroscience and Multicellular organism.
His study in the field of Antitumor immunity is also linked to topics like Context.
Between 2017 and 2021, his most popular works were:
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. (1421 citations)
- Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover (89 citations)
- Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients (56 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Autophagy, Programmed cell death, Cancer cell, Apoptosis and Cancer research.
His research integrates issues of Cell, Cancer, Transcription factor, Cell biology and Neuroscience in his study of Autophagy.
His Neuroscience research is multidisciplinary, incorporating perspectives in Pyroptosis, Entosis and Immunogenic cell death.
His Programmed cell death research includes themes of Chaperone-mediated autophagy, Computational biology and Autolysosome.
His work carried out in the field of Cancer cell brings together such families of science as Cas9, Downregulation and upregulation, Gene, CRISPR and Proteasome.
His studies deal with areas such as Gene expression, Metastasis, Cytotoxic T cell, Bafilomycin and In vivo as well as Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
